South Korea’s ability to quickly manufacture and distribute diagnostics has been an important factor in controlling the spread of COVID-19 within the country, the US Food and Drug Administration says in a new report.
The 25 May document explains that the agency began looking into the South Korean approach in April 2020 after “numerous sources around the world declared South Korea’s response strategy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?